IL6 and hepatocellular carcinoma: In the case of human hepatocellular carcinoma (HCC), TAM (tumor-associated macrophage)-derived IL-37 impedes their polarization towards the M2 phenotype by affecting the IL-6/STAT3 axis, eventually inhibiting the growth of the tumor [19].